Dental Pulp Regeneration by Autologous Tissue Transplantation
NCT ID: NCT03833401
Last Updated: 2019-02-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2019-02-01
2021-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Survival of Inflamed Mature Single Rooted Teeth
NCT03725514
Development of a Model to Evaluate Regenerative Endodontic Techniques Using Extract Human Teeth
NCT00595595
Regenerative Endodontic Therapy in Cases of Irreversible Pulpitis
NCT06525844
Cell-free Autologous Regenerative Endodontics Treatment for Teeth With Periapical Lesions (CARETT)
NCT05305417
DPBRN Persistent Pain and Root Canal Therapy
NCT01201668
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Root canal revascularization
Root canal disinfection and revascularization without tissue transplantation. This will serve as control group.
Root canal revascularization
Root canal disinfection and revascularization without tissue transplantation
Autologous tissue transplantation
Root canal disinfection will be performed and revascularization will be induced with autologous tissue transplantation.
Autologous tissue transplantation
Root canal disinfection and revascularization with patient's own minced pulp tissues
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Root canal revascularization
Root canal disinfection and revascularization without tissue transplantation
Autologous tissue transplantation
Root canal disinfection and revascularization with patient's own minced pulp tissues
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants presenting with donor pulp tissue, either from existing deciduous teeth or from permanent teeth treatment planned for extraction, e.g., second premolars for orthodontic extraction or third molars.
* Participants presenting with irreversible pulpitis and partial necrosis, i.e., visible pulpal tissues during access opening and canal debridement.
* Participants with immature root apices, including those with partially closed apex, that require root canal procedure.
Exclusion Criteria
* Participants with avulsed, replanted teeth with resultant pulp necrosis.
* Participants with vertical root fracture/cracks.
* Participants with teeth that are not restorable.
7 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Los Angeles
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mo K. Kang, DDS, PhD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mo Kang, DDS,PhD
Role: PRINCIPAL_INVESTIGATOR
University of California, Los Angeles
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCLA School of Dentistry
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18-000077
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.